EFFECT OF PEMVIDUTIDE, A GLP-1/GLUCAGON DUAL RECEPTOR AGONIST, ON PLASMA LIPIDOMIC PROFILES IN SUBJECTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)

pemvidutide (ALT-801) - Altimmune

John Suschak1; Maynara Lucca Andrade1; Bertrand Georges1; Sarah Browne1; Christina Alonso2; Scott Harris1; Scot Roberts1

Oct 15, 2024